Stay updated on ORION-3 Extension Trial: Inclisiran in Cardiovascular Disease Clinical Trial
Sign up to get notified when there's something new on the ORION-3 Extension Trial: Inclisiran in Cardiovascular Disease Clinical Trial page.

Latest updates to the ORION-3 Extension Trial: Inclisiran in Cardiovascular Disease Clinical Trial page
- CheckyesterdayChange DetectedThe revision label on the site moved from v3.6.3 to v3.6.4, indicating an internal update. This does not affect the visible content or layout of the page.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedA newer revision tag v3.6.3 was added and an older tag v3.6.0 was removed, indicating a minor version update to the page's underlying system or documentation.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page now displays a note that no more participants are being recruited and includes a revision tag (v3.6.0). Concurrently, multiple enrollment-related sections were deleted or collapsed, changing how participant counts and enrollment details are presented on the results page.SummaryDifference1%

- Check52 days agoChange DetectedPage revision updated from v3.5.4 to v3.5.5, indicating a minor backend update. There are no visible changes to the page content or study results.SummaryDifference0.0%

- Check75 days agoChange DetectedThe page now references Revision: v3.5.4, replacing Revision: v3.5.3, indicating a minor revision update to the page's release notes.SummaryDifference0.0%

- Check96 days agoChange DetectedThe page’s “Revision” (site/system version) label was updated from v3.5.0 to v3.5.3, reflecting a backend or platform update rather than a change to the displayed study results.SummaryDifference0.0%

Stay in the know with updates to ORION-3 Extension Trial: Inclisiran in Cardiovascular Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ORION-3 Extension Trial: Inclisiran in Cardiovascular Disease Clinical Trial page.